NCT07144345View on ClinicalTrials.gov

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

June 29, 2026

Study Completion Date

September 24, 2026

Conditions
Actinic Keratosis
Interventions
DRUG

Reformulated Levulan Kerastick containing aminolevulinic acid hydrochloride (ALA HCl), 20%

Solution for topical use

OTHER

Vehicle containing excipients only (VEH) without active ingredient

Solution for topical use

DEVICE

Blue Light Photodynamic Therapy Illuminator device, BLU-U® model 4170E

BLU-U® blue light Photodynamic Therapy (PDT) illuminator

All Listed Sponsors
lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY